1. Home
  2. NSPR vs XTNT Comparison

NSPR vs XTNT Comparison

Compare NSPR & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.35

Market Cap

72.1M

Sector

Health Care

ML Signal

HOLD

Logo Xtant Medical Holdings Inc.

XTNT

Xtant Medical Holdings Inc.

HOLD

Current Price

$0.51

Market Cap

68.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
XTNT
Founded
2005
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.1M
68.9M
IPO Year
2009
2009

Fundamental Metrics

Financial Performance
Metric
NSPR
XTNT
Price
$1.35
$0.51
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$4.00
$1.00
AVG Volume (30 Days)
44.7K
183.7K
Earning Date
05-08-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
125.00
EPS
N/A
0.03
Revenue
$2,310,000.00
$53,337,000.00
Revenue This Year
$57.98
N/A
Revenue Next Year
$95.41
$9.30
P/E Ratio
N/A
$15.89
Revenue Growth
N/A
N/A
52 Week Low
$1.28
$0.39
52 Week High
$2.93
$0.95

Technical Indicators

Market Signals
Indicator
NSPR
XTNT
Relative Strength Index (RSI) 31.84 44.42
Support Level N/A $0.44
Resistance Level $2.50 $0.68
Average True Range (ATR) 0.11 0.04
MACD -0.03 -0.00
Stochastic Oscillator 11.11 49.67

Price Performance

Historical Comparison
NSPR
XTNT

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About XTNT Xtant Medical Holdings Inc.

Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.

Share on Social Networks: